Copy
View email in your browser

Immune Pharmaceuticals Provides Business Update
and Full Year 2015 Financial Results

Los Angeles - New York, March 31, 2016 -  Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced financial results for the fourth quarter and full year ended December 31, 2015. Immune filed its Annual Report on Form 10-K for fiscal year 2015 on March 30, 2016.



Please visit our sites www.stockwatchindex.com and  www.swiresearch.com. We would appreciate if you could
pass our newsletter on to your friends and colleagues. We always appreciate your feedback and comments.

If you are interested in a research report for your public company, please contact us at info@swiresearch.com.
 

                                        


Rainer Poertner - Chief Analyst    

StockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI may have been compensated for the  publication of the information herein and may hold positions in any of the stocks mentioned, which could be considered a conflict of interest. The included information is subject to change without notice. Please visit www.swiresearch.com/#!legal-ease/lmvw1  for a full text of our Disclaimer, Privacy policy and Terms of Use.
Copyright © 2016 DynamicMarketConcepts, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp